|SEQ_NO||1||Date of announcement||2022/06/13||Time of announcement||13:42:19|
|Subject||Announcement of TTY Biopharm's unaudited income information in May 2022|
|Date of events||2022/06/13||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2022/06/13
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $418,208 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $123,061 thousands, and a consolidated income before tax of $128,957 thousands in May 2022; net income attributed to stockholders of the company was $102,847 thousands; EPS is $0.41.
Year-to-date consolidated net sales was $1,827,628 thousands (in NT dollars; unaudited), a consolidated operating profit was $477,287 thousands and consolidated income before tax was $537,174 thousands until May 2022; year-to-date net income attributed to stockholders of the company was $427,476 thousands; EPS is $1.72.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.